Driehaus Capital Management’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-129,852
Closed -$1.63M 625
2014
Q4
$1.63M Buy
129,852
+2,818
+2% +$38.4K 0.07% 347
2014
Q3
$1.84M Sell
127,034
-19,940
-14% -$289K 0.07% 341
2014
Q2
$2.29M Buy
+146,974
New +$2.23M 0.07% 317

Other funds holding TRIV

Driehaus Capital Management's TRIV Position: Q1 2015 in Review

Driehaus Capital Management sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q1 2015, closing a stake of 129,852 shares — an estimated $1.63M sold.

Driehaus Capital Management first reported a position in TRIV in Q2 2014 and held it in 3 quarters. The position peaked at $2.29M in Q2 2014. 38 funds tracked by Wall St. Rank hold TRIV as of Q1 2015.

  • Driehaus Capital Management reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q1 2015 after selling out during the quarter.
  • Driehaus Capital Management sold 129,852 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q1 2015, an estimated $1.63M.
  • Driehaus Capital Management first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 3 quarters.
  • Driehaus Capital Management's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $2.29M in Q2 2014.
  • 38 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q1 2015.

Based on Driehaus Capital Management's 13F filing for Q1 2015, filed 15 May 2015.